摘要

Background: The ability to accurately assess tumor size in ductal carcinoma in situ (DCIS) is an important clinical issue when selecting the appropriate treatment plan. Purpose: To compare the accuracy of using mammography, ultrasound (US), and magnetic resonance imaging (MRI) to assess DCIS tumor size based on imaging and histopathological findings. Material and Methods: Fifty-six patients with DCIS were included. Mammography, US, and MRI were reviewed, and the accuracy of the measured tumor sizes were compared with the imaging and histopathological parameters. Results: If visible, tumor measurements demonstrated high reliability with the pathologically determined size, with the best results obtained using US (k = 0.851) followed by mammography (k = 0.815) and MRI (k = 0.738). Tumor size assessment was significantly more accurate when the lesion was shown as a mass on US (P = 0.003) or MRI (P < 0.001) with minimal and mild background parenchymal enhancement (P = 0.016) on MRI. When mammography was used to assess tumor size, the tumors with positive estrogen receptor status and luminal A subtype demonstrated a significantly more accurate tumor size. Conclusion: The combination of US and MRI, in addition to mammography, has an important role in assessing the exact tumor extent of DCIS.

  • 出版日期2017-12